The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 05, 2019
Filed:
Feb. 01, 2017
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Joseph Hedrick, New Hope, PA (US);
Elizabeth C. Hsia, Kenneth Square, PA (US);
Paul Imm, Newtown, PA (US);
Jocelyn Leu, Ambler, PA (US);
Bethany Paxson, Philadelphia, PA (US);
Mark Rigby, Abington, PA (US);
Songmao Zheng, Ambler, PA (US);
Ramineh Zoka, Lower Gwynedd, PA (US);
Assignee:
Janssen Biotech, Inc., Horsham, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61P 3/10 (2006.01); A61P 29/00 (2006.01); A61M 5/00 (2006.01); A61M 5/315 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/241 (2013.01); A61M 5/003 (2013.01); A61M 5/31533 (2013.01); A61M 5/31573 (2013.01); A61M 5/31591 (2013.01); A61P 3/10 (2018.01); A61P 29/00 (2018.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01);
Abstract
The present invention relates to compositions and methods utilizing anti-TNF antibodies having a heavy chain (HC) comprising SEQ ID NO:36 and a light chain (LC) comprising SEQ ID NO:37 for use in the treatment or prevention of Type I Diabetes (T1D).